Rubella antibody in antenatal clinic patients [8]

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 2, 1999, Pages 284-

  Sintchenko, V ^a   Field, P R ^a   Gilbert, G L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA ANTIBODY;

IMMUNE RESPONSE; IMMUNIZATION; LETTER; REINFECTION; SEROLOGY; VACCINATION; VIREMIA;

EID: 0032949943     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00703.x     Document Type: Letter

References (7)

1. 1. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996; 106: 170-3.
2. 2. Davis WJ, Larson HE, Simsarian JP, Parkman PD, Meyer HM. A study of rubella immunity and resistance to infection. JAMA 1971; 215: 600-8.
3. 3. Katow S, Sugiura A. Antibody response to individual rubella virus proteins in congenital and other rubella virus infections. J Clin Microbiol 1985; 21: 449-51.
4. 4.Mitchell LA, Ho MK-L, Rogers JE et al. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals. J Clin Microbiol 1996; 34: 2210-18.
5. 5. Morgan-Capner P. Rubella serodiagnosis. Serodiagn Immunother Infect Dis 1993; 1: 5-7.
6. 6. Field PR, Murphy AM, Cape SF, Albrey MB. Experience with the use of trypsinized human group O erythrocytes in the rubella haemagglutination inhibition test. Aust J Med Technol 1977; 8: 48-54.
7. 7. Horstmann DM, Schluederberg A, Emmons JE et al. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection. Rev Infect Dis 1985; 7: 580-5.